NECTIN4 and cancer: In addition, since nectin-4 has been proposed as a new therapeutic target for antibody-based cancer treatment (39) and oncolytic measles virotherapy, which utilizes nectin-4 as a receptor (40–42), the scFvs could also be useful for screening suitable candidates to receive such nectin-4-targeted treatments.